Table 2.

Baseline estimates and distributions of praziquantel costs and efficacies as well as antiretroviral therapy coverage

Variable	Baseline value, US $	Distribution	Ref(s).
Cost per praziquantel tablet (600 mg)	0.08	NA	30
Cost of delivery of praziquantel per individual	0.21	Min = 0.06, Max = 0.81 (uniform)	42
Efficacy of MDA praziquantel (schistosomiasis cure rate)	0.80	Min = 0.57, Max = 0.93 (uniform)	30
Efficacy of MDA praziquantel (reduction of the risk for acquiring FGS)	0.5	Min = 0.4, Max = 0.7 (uniform)	11
ART coverage (proportion HIV patients receiving ART)	0.34	Mean = 0.34, SD = 0.02 (normal)	33
Zimbabwe non-HIV/AIDS health expenditure (cost per person per annum)	26	Mean = 26, SD = 4.8 (gamma)	21, 43
Cost lifetime ART (ARV first line, ARV second line, ARV monitoring)	3,000	NA	55
Other lifetime cost of HIV treatment (prophylaxis and treatment of opportunistic infections, diagnostic and routine testing, palliative care)	695	NA	55

ART, antiretroviral therapy; ARV, antiretroviral; MDA, mass drug administration; Max, maximum; Min, minimum; NA, not applicable.